Our study demonstrated a significant correlation between CD36 immunostaining and shorter both DFS and OS in patients with bladder carcinoma which means that CD36 overexpression was concomitant with tumors displaying highly aggressive behavior. This evidence concerns the gene CD36 and urinary bladder carcinoma.